Sublingual atropine drops for the treatment of pediatric sialorrhea

J Pain Symptom Manage. 2010 Nov;40(5):783-8. doi: 10.1016/j.jpainsymman.2010.02.007. Epub 2010 Jun 11.

Abstract

Excess oral secretions or sialorrhea is a common problem affecting children and adults with neurological disorders, as well as those approaching the end of life because of a variety of underlying illnesses. Systemic anticholinergic medications are often prescribed in an attempt to improve quality of life and reduce complications; yet, response rates are variable, and a sizable proportion of patients discontinue these drugs as a result of intolerable side effects. This report describes the successful use of a local treatment, sublingually delivered ophthalmic atropine drops, to reduce sialorrhea in a child receiving palliative care. In addition, medical evidence for the safety and efficacy of traditionally prescribed systemic medications for the treatment of pediatric sialorrhea is reviewed.

Publication types

  • Case Reports

MeSH terms

  • Administration, Sublingual
  • Adolescent
  • Atropine / administration & dosage*
  • Humans
  • Leukodystrophy, Metachromatic / complications*
  • Male
  • Muscarinic Antagonists / administration & dosage
  • Palliative Care
  • Sialorrhea / complications
  • Sialorrhea / drug therapy*
  • Treatment Outcome

Substances

  • Muscarinic Antagonists
  • Atropine
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy